97;late matur alpha amylas lma wheat genet defect caus synthesi high isoelectr point alpha amylas follow temperatur shock mid grain develop prolong cold grain develop lead starch degrad physiolog understood biochem mechan involv grain lma respons remain unclear appli high throughput proteom wheat flour display rang lma activ use array statist analys select lma respons biomark mine use suit tool applic wheat protein observ lma affect grain activ primari metabol glycolysi gluconeogenesi tca cycl dna rna bind mechan protein translat logic transit protein fold activ driven chaperon protein disulfid isomeras protein assembl dimeris complex secondari metabol mobil upregul phytohormon chemic defenc respons lma invok cellular structur includ ribosom microtubul chromatin final unsurprisingli lma express greatli impact grain storag protein starch carbohydr upregul alpha gliadin starch metabol lmw glutenin stachyos sucros udp galactos udp glucos downregul knowledg proteom studi tackl wheat lma issu largest plant bas proteom studi publish date logist technic requir bottleneck ambiti large scal high throughput proteom experi challeng associ big data analys discuss
103;neurolog covid diseas report wide publish studi lack inform neurolog outcom prognost risk factor aim spectrum neurolog diseas hospitalis covid patient characteris clinic outcom investig factor associ poor outcom conduct individu patient data ipd meta analysi hospitalis patient neurolog covid diseas use standard case definit invit author studi pandem wave plu clinician global covid neuro network unpublish data contribut analys featur associ poor outcom moder sever disabl death modifi rankin scale use multivari model includ studi unpublish provid ipd patient covid acut new onset neurolog diseas encephalopathi patient cerebrovascular event common diagnos respiratori system symptom preced neurolog featur patient develop neurolog diseas hospit admiss poor outcom common patient cerebrovascular event ci encephalopathi intens care use high overal greater cerebrovascular patient cerebrovascular encephalopath patient risk factor poor outcom includ breathless admiss elev d dimer overal day mortal hazard death compar lower patient european region neurolog covid diseas pose consider burden term diseas outcom use hospit resourc prolong intens care inpati admiss preliminari data suggest differ accord region countri incom level differ risk factor encephalopathi stroke suggest differ diseas mechan amen intervent especi develop neurolog symptom hospit admiss
4;cdc recommend number mitig behavior prevent spread sars cov viru caus coronaviru diseas covid behavior includ cover nose mouth mask protect possibl infect public set person live outsid one s household ill household member maintain feet meter distanc person live outsid one s household keep oneself distant person ill wash hand soap water second or soap water avail use hand sanit contain alcohol age posit associ mask use known recommend mitig behavior monitor mitig behavior cours pandem inform target commun behavior modif strategi slow spread covid data foundat covid impact survey collect nation repres data report mitig behavior april jun adult unit state age year report use face mask increas april may reach june howev report mitig behavior e g hand wash social distanc avoid public crowd place declin margin remain unchang time point preval report mitig behavior lowest younger adult age year highest older adult age year lower engag mitig behavior younger adult reason increas incid confirm covid case group shown preced increas year find underscor need priorit clear target messag behavior modif intervent especi young adult encourag uptak support mainten recommend mitig behavior prevent spread covid
1;object precari employ pe term use non standard employ form character low secur neg effect mental health object review systemat review evid effect pe mental health identifi import area research method protocol develop follow prisma p guidelin web scienc pubm psycinfo search septemb uniqu record assess elig qualiti review data includ studi summar forest plot meta analys use random effect model evid qualiti rate use grade method result obtain uniqu record studi suffici qualiti met inclus criteria moder qualiti evid grade score advers effect job insecur mental health summari odd ratio or confid interv ci low qualiti grade evid effect temporari employ unpredict work hour mental health studi multidimension exposur show advers effect weight averag ci conclus research pe mental health grow high qual prospect studi scarc job insecur like advers effect mental health clear multi dimension definit pe lack harmon effort need single vari observ studi job insecur temporari employ priorit
8;polyphenol long recogn health promot entiti includ benefici effect cardiovascular diseas reput boost recent follow number encourag clinic studi multipl chronic patholog valid efficaci health benefit polyphenol link well establish power antioxid activ review aim provid comprehens up to d knowledg current therapeut statu polyphenol have suffici heed treatment cardiovascular diseas furthermor data safeti profil highli efficaci polyphenol investig enhanc role cardiac abnorm evid present support action phenol deriv cardiovascular patholog follow receptor signal pathway ultim caus chang endogen antioxid antiplatelet vasodilatori anti inflammatori activ addit vitro antioxid pre clin clinic experi anti inflammatori immunomodulatori attribut polyphenol reveal role cardioprotect agent howev obviou shortag vivo studi relat dose select toxic polyphenol make compound suitabl target clinic investig studi need develop safe potent herbal product cardiovascular diseas novelti review provid comprehens knowledg polyphenol safeti health claim help research identifi moieti like exert protect therapeut effect cardiovascular diseas
92;peopl experi prolong symptom follow acut covid infect includ fatigu chest pain breathless headach cognit impair symptom persist week follow initi infect explain altern diagnosi term post covid syndrom use patient defin term long covid understand live experi long covid crucial support manag howev research patient experi long covid current ethnic divers enough studi aim explor live experi long covid use qualit interview art bas method peopl ethnic divers background in uk better understand wider system support healthcar support need co creat artwork use build interview find purpos sampl strategi use gain divers experi long covid sampl demograph geograph locat experi long covid individu age year black ethnic minor background self report long covid symptom invit semi structur interview interview analys themat sub sampl particip invit co creat visual artwork explor share narr long covid enhanc storytel increas understand condit patient advisori group repres divers ethnic experi long covid inform research stage stakehold workshop healthcar profession person system network import peopl s manag long covid advis integr find inform manag long covid studi use patient narr peopl divers ethnic background rais awar long covid help inform manag long covid wider social system network inform better healthcar servic access experi
35;atherosclerosi major cardiovascular diseas caus ischemia heart brain extrem lead infarct hypolipidem agent atorvastatin calcium ato allevi atherosclerosi reduc plasma lipid inflammatori factor howev low bioavail ato limit widespread use clinic effect curcumin cur natur polyphenol antioxid anti inflamm bioactiv potenti anti atherosclerosi activ reduc ato induc cytotox liposom modifi use target ligand e selectin bind peptid prepar co deliv ato cur dysfunct endotheli cell ec overexpress e selectin molecul involv inhibit adhes e selectin intercellular cell adhes molecule icam inflamm il monocyt chemotact protein mcp human aortic endotheli cell evalu use real tim quantit pcr flow cytometri immunofluoresc stain antiatherosclerosi effect liposom co load ato cur vivo evalu use apo knockout apoe mice target liposom deliv ato cur dysfunct ec result synergist suppress adhes molecul e selectin icam plasma lipid level moreov treatment reduc foam cell format secret inflammatori factor il mcp block monocyt migrat intima addit cur success reduc ato induc cytotox vitro vivo experi demonstr cell target co deliveri ato cur dysfunct ec drastic reduc atherosclerot lesion fewer effect ato cur alon
